{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T03:53:58Z","timestamp":1785038038403,"version":"3.55.0"},"reference-count":89,"publisher":"Bentham Science Publishers Ltd.","issue":"22","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Genetically modified micro-organisms like bacteria, viruses, algae and fungi are novel\napproaches used in the field of healthcare due to better efficacy and targeted delivery in comparison to conventional\napproaches.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>This review article focuses on the applications of genetically modified micro-organisms in the\ntreatment of cancer, obesity and HIV infection. The gut microbiome causes metabolic disorders, however, the\nuse of genetically modified bacteria alters the gut microbiota and delivers therapeutically effective drugs in the\ntreatment of obesity.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Enhancement of the therapeutic activity of different micro-organisms is required for multiple treatments\nin cancer, diabetes, etc., by incorporating their fragments into the microbial filaments with the help of\ngenetic modification approaches. Various methods like amelioration of NAPE synthesis, silica immobilization,\npolyadenylation and electrochemical are used to integrate the strain into the bacteria and engineer a live virus\nwith a peptide.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The development of novel microbial strains using genetic modifications over core strains offers higher\nprecision, greater molecular multiplicity, better prevention from the degradation of microbes in atmospheric\ntemperature and significant reduction of side effects for therapeutic applications. Moreover, genetically modified\nmicro-organisms are used in multidisciplinary sectors like generation of electricity, purification of water,\nbioremediation process, etc., indicating the versatility and scope of genetically engineered microbes.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The bioengineered micro-organisms with genetic modifications proved to be advantageous in various\nconditions like cancer, diabetes, malaria, organ regeneration, inflammatory bowel disease, etc. This article\nprovides insight into various applications of genetically modified microbes in different sectors with their implementation\nfor regulatory approval.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1381612828666220128102823","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T11:59:35Z","timestamp":1643371175000},"page":"1833-1842","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Multifaceted Applications of Genetically Modified Micro-organisms: A Biotechnological\nRevolution"],"prefix":"10.2174","volume":"28","author":[{"given":"Vasavi","family":"Basarkar","sequence":"first","affiliation":[{"name":"Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management,\nSVKM\u2019s NMIMS, V.L. Mehta Road, Vile Parle (W), Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharayu","family":"Govardhane","sequence":"additional","affiliation":[{"name":"Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management,\nSVKM\u2019s NMIMS, V.L. Mehta Road, Vile Parle (W), Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8144-7645","authenticated-orcid":true,"given":"Pravin","family":"Shende","sequence":"additional","affiliation":[{"name":"Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management,\nSVKM\u2019s NMIMS, V.L. Mehta Road, Vile Parle (W), Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1423-0127-17-21","volume":"17","author":"Patyar S.","year":"2010","unstructured":"Patyar S.; Joshi R.; Byrav D.S.; Prakash A.; Medhi B.; Das B.K.; Bacteria in cancer therapy: A novel experimental strategy. J Biomed Sci 2010,17(1),21","journal-title":"J Biomed Sci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nm0896-883","volume":"2","author":"Prakash S.","year":"1996","unstructured":"Prakash S.; Chang T.M.; Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats. Nat Med 1996,2(8),883-887","journal-title":"Nat Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1172\/JCI72517","volume":"124","author":"Chen Z.","year":"2014","unstructured":"Chen Z.; Guo L.; Zhang Y.; Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity. J Clin Invest 2014,124(8),3391-3406","journal-title":"J Clin Invest"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/S1470-2045(03)01194-X","volume":"4","author":"Pawelek J.M.","year":"2003","unstructured":"Pawelek J.M.; Low K.B.; Bermudes D.; Bacteria as tumour-targeting vectors. Lancet Oncol 2003,4(9),548-556","journal-title":"Lancet Oncol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1074\/jbc.M607809200","volume":"282","author":"Fu J.","year":"2007","unstructured":"Fu J.; Astarita G.; Gaetani S.; Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine. J Biol Chem 2007,282(2),1518-1528","journal-title":"J Biol Chem"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"e26695","DOI":"10.1371\/journal.pone.0026695","volume":"6","author":"Crawfurd KJ","year":"2011","unstructured":"Crawfurd KJ; Raven JA; Wheeler GL; Baxter EJ; Joint I; The\nresponse of Thalassiosira pseudonana to long-term exposure to increased\nCO2 and decreased pH. 2011,6(10),e26695"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1126\/science.1199115","volume":"331","author":"Fang W.","year":"2011","unstructured":"Fang W.; Vega-Rodr\u00edguez J.; Ghosh A.K.; Jacobs-Lorena M.; Kang A.; St Leger R.J.; Development of transgenic fungi that kill human malaria parasites in mosquitoes. Science 2011,331(6020),1074-1077","journal-title":"Science"},{"key":"ref=8","first-page":"378","author":"Blanquet-Diot S.","year":"2007","unstructured":"Blanquet-Diot S.; Garrait G.; Jarrige J.; Alric M.; Genetically modified\nyeasts as a new oral drug delivery system: from in vitro to in\nvivo validation of the concept. In: Communicating Current Research\nand Educational Topics and Trends in Applied Microbiology. Formatex, Spain 2007,378-90","journal-title":"Formatex, Spain"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.bbrc.2004.12.080","volume":"327","author":"Pandey G.","year":"2005","unstructured":"Pandey G.; Paul D.; Jain R.K.; Conceptualizing \u201csuicidal genetically engineered microorganisms\u201d for bioremediation applications. Biochem Biophys Res Commun 2005,327(3),637-639","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.3389\/fmicb.2019.02078","volume":"10","author":"Lovley D.R.","year":"2019","unstructured":"Lovley D.R.; Walker D.J.F.; Geobacter protein nanowires. Front Microbiol 2019,10,2078","journal-title":"Front Microbiol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1128\/CDLI.8.3.545-551.2001","volume":"8","author":"Chatel J.M.","year":"2001","unstructured":"Chatel J.M.; Langella P.; Adel-Patient K.; Commissaire J.; Wal J.M.; Corthier G.; Induction of mucosal immune response after intranasal or oral inoculation of mice with Lactococcus lactis producing bovine beta-lactoglobulin. Clin Diagn Lab Immunol 2001,8(3),545-551","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/acer.13626","volume":"42","author":"Purohit K.","year":"2018","unstructured":"Purohit K.; Parekh P.K.; Kern J.; Pharmacogenetic manipulation of the nucleus accumbens alters binge\u2010like alcohol drinking in mice. Alcohol Clin Exp Res 2018,42(5),879-888","journal-title":"Alcohol Clin Exp Res"},{"key":"ref=13","first-page":"8751","volume":"61","author":"McCart J.A.","year":"2001","unstructured":"McCart J.A.; Ward J.M.; Lee J.; Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes. Cancer Res 2001,61(24),8751-8757","journal-title":"Cancer Res"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev.nutr.21.1.323","volume":"21","author":"Wing R.","year":"2001","unstructured":"Wing R.; Hill J.; Successful weight loss maintenance. Annu Rev Nutr 2001,21,323-341","journal-title":"Annu Rev Nutr"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/archinte.1959.00270010085011","volume":"103","author":"Stunkard A.","year":"1959","unstructured":"Stunkard A.; McLAREN-HUME M. The results of treatment for obesity: a review of the literature and report of a series. AMA Arch Intern Med 1959,103(1),79-85","journal-title":"AMA Arch Intern Med"},{"key":"ref=16","first-page":"123","volume":"13","author":"Kramer F.M.","year":"1989","unstructured":"Kramer F.M.; Jeffery R.W.; Forster J.L.; Snell M.K.; Long-term follow-up of behavioral treatment for obesity: patterns of weight regain among men and women. Int J Obes 1989,13(2),123-136","journal-title":"Int J Obes"},{"key":"ref=17","first-page":"39","volume":"13","author":"Wadden T.A.","year":"1989","unstructured":"Wadden T.A.; Sternberg J.A.; Letizia K.A.; Stunkard A.J.; Foster G.D.; Treatment of obesity by very low calorie diet, behavior therapy, and their combination: a five-year perspective. Int Obes 1989,13(Suppl. 2),39-46","journal-title":"Int Obes"},{"key":"ref=18","first-page":"879151","volume":"2012","author":"Harris K.","year":"2012","unstructured":"Harris K.; Kassis A.; Major G.; Chou C.J.; Is the gut microbiota a new factor contributing to obesity and its metabolic disorders? J Obes 2012,2012,879151","journal-title":"J Obes"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Wang Z.","year":"2011","unstructured":"Wang Z.; Elizabeth K.; Brian J.B.; Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011,472(7341),57-63","journal-title":"Nature"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nature07540","volume":"457","author":"Turnbaugh P.J.","year":"2009","unstructured":"Turnbaugh P.J.; Hamady M.; Yatsunenko T.; A core gut microbiome in obese and lean twins. Nature 2009,457(7228),480-484","journal-title":"Nature"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nature05414","volume":"444","author":"Turnbaugh P.J.","year":"2006","unstructured":"Turnbaugh P.J.; Ley R.E.; Mahowald M.A.; Magrini V.; Mardis E.R.; Gordon J.I.; An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006,444(7122),1027-1031","journal-title":"Nature"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"18734","DOI":"10.1074\/jbc.M109.005744","volume":"284","author":"Faure L.","year":"2009","unstructured":"Faure L.; Coulon D.; Laroche-Traineau J.; Discovery and characterization of an Arabidopsis thaliana N-acylphosphatidyl-ethanolamine synthase. J Biol Chem 2009,284(28),18734-18741","journal-title":"J Biol Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ab.2010.06.027","volume":"405","author":"Guo L.","year":"2010","unstructured":"Guo L.; Amarnath V.; Davies S.S.; A liquid chromatography-tandem mass spectrometry method for measurement of N-modified phosphatidylethanolamines. Anal Biochem 2010,405(2),236-245","journal-title":"Anal Biochem"},{"key":"ref=24","year":"2017","unstructured":"Genetic treatment for blindness may soon be reality. Science Daily Available from: 2017"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1194\/jlr.M013391","volume":"52","author":"Thabuis C.","year":"2011","unstructured":"Thabuis C.; Destaillats F.; Lambert D.M.; Lipid transport function is the main target of oral oleoylethanolamide to reduce adiposity in high-fat-fed mice. J Lipid Res 2011,52(7),1373-1382","journal-title":"J Lipid Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/j.1365-2982.2008.01248.x","volume":"21","author":"Cluny N.L.","year":"2009","unstructured":"Cluny N.L.; Keenan C.M.; Lutz B.; Piomelli D.; Sharkey K.A.; The identification of peroxisome proliferator-activated receptor \u03b1-independent effects of oleoylethanolamide on intestinal transit in mice. Neurogastroenterol Motil 2009,21(4),420-429","journal-title":"Neurogastroenterol Motil"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00109-008-0305-7","volume":"86","author":"Aviello G.","year":"2008","unstructured":"Aviello G.; Matias I.; Capasso R.; Inhibitory effect of the anorexic compound oleoylethanolamide on gastric emptying in control and overweight mice. J Mol Med (Berl) 2008,86(4),413-422","journal-title":"J Mol Med (Berl)"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/35102582","volume":"414","author":"Rodr\u00edguez de Fonseca F.","year":"2001","unstructured":"Rodr\u00edguez de Fonseca F.; Navarro M.; G\u00f3mez R.; An anorexic lipid mediator regulated by feeding. Nature 2001,414(6860),209-212","journal-title":"Nature"},{"key":"ref=29","first-page":"1769","volume":"135","author":"Scoot B.","year":"1989","unstructured":"Scoot B.; Mulrooney H.; Regulation of gene expression and cellular localization of cloned K. aerogens urease. J Gen Microbiol 1989,135,1769-1776","journal-title":"J Gen Microbiol"},{"key":"ref=30","first-page":"473","volume":"15","author":"Malmgren R.A.","year":"1955","unstructured":"Malmgren R.A.; Flanigan C.C.; Localization of the vegetative form of Clostridium tetani in mouse tumors following intravenous spore administration. Cancer Res 1955,15(7),473-478","journal-title":"Cancer Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1128\/AAC.00493-06","volume":"50","author":"Liu X.","year":"2006","unstructured":"Liu X.; Lagenaur L.A.; Simpson D.A.; Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N. Antimicrob Agents Chemother 2006,50(10),3250-3259","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.copbio.2015.05.004","volume":"35","author":"Ero-Lambea C.P.","year":"2015","unstructured":"Ero-Lambea C.P.; -Gallego Ruano, A\u2019ngel Fernandez L. Engineered bacteria as therapeutic agents. Curr Opin Biotechnol 2015,35,94-102","journal-title":"Curr Opin Biotechnol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.1073\/pnas.0936260100","volume":"100","author":"Suzuki A.","year":"2003","unstructured":"Suzuki A.; Nakauchi H.; Taniguchi H.; Glucagon-like peptide 1 (1-37) converts intestinal epithelial cells into insulin-producing cells. Proc Natl Acad Sci USA 2003,100(9),5034-5039","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.surg.2005.06.008","volume":"138","author":"Koizumi M.","year":"2005","unstructured":"Koizumi M.; Doi R.; Fujimoto K.; Pancreatic epithelial cells can be converted into insulin-producing cells by GLP-1 in conjunction with virus-mediated gene transfer of pdx-1. Surgery 2005,138(2),125-133","journal-title":"Surgery"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.surg.2006.06.014","volume":"140","author":"Koizumi M.","year":"2006","unstructured":"Koizumi M.; Nagai K.; Kida A.; Forced expression of PDX-1 induces insulin production in intestinal epithelia. Surgery 2006,140(2),273-280","journal-title":"Surgery"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nbt1077","volume":"23","author":"Majander K.","year":"2005","unstructured":"Majander K.; Anton L.; Antikainen J.; Extracellular secretion of polypeptides using a modified Escherichia coli flagellar secretion apparatus. Nat Biotechnol 2005,23(4),475-481","journal-title":"Nat Biotechnol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.talanta.2010.05.046","volume":"82","author":"Catterall K.","year":"2010","unstructured":"Catterall K.; Robertson D.; Hudson S.; Teasdale P.R.; Welsh D.T.; John R.; A sensitive, rapid ferricyanide-mediated toxicity bioassay developed using Escherichia coli. Talanta 2010,82(2),751-757","journal-title":"Talanta"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1139\/m69-077","volume":"15","author":"Chang P.C.","year":"1969","unstructured":"Chang P.C.; Blackwood A.C.; Simultaneous production of three phenazine pigments by Pseudomonas aeruginosa Mac 436. Can J Microbiol 1969,15(5),439-444","journal-title":"Can J Microbiol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bios.2011.08.032","volume":"30","author":"Yong Y.C.","year":"2011","unstructured":"Yong Y.C.; Yu Y.Y.; Li C.M.; Zhong J.J.; Song H.; Bioelectricity enhancement via overexpression of quorum sensing system in Pseudomonas aeruginosa-inoculated microbial fuel cells. Biosens Bioelectron 2011,30(1),87-92","journal-title":"Biosens Bioelectron"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/nnano.2014.236","volume":"9","author":"Malvankar N.S.","year":"2014","unstructured":"Malvankar N.S.; Yalcin S.E.; Tuominen M.T.; Lovley D.R.; Visualization of charge propagation along individual pili proteins using ambient electrostatic force microscopy. Nat Nanotechnol 2014,9(12),1012-1017","journal-title":"Nat Nanotechnol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"8354","DOI":"10.1039\/C5RA28092C","volume":"6","author":"Adhikari R.","year":"2016","unstructured":"Adhikari R.; Malvankar N.; Tuominen M.; Lovley D.; Conductivity of individual Geobacter pili. RSC Advances 2016,6,8354","journal-title":"RSC Advances"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1126\/science.1158241","volume":"320","author":"Shih C.","year":"2008","unstructured":"Shih C.; Museth A.K.; Abrahamsson M.; Tryptophan-accelerated electron flow through proteins. Science 2008,320(5884),1760-1762","journal-title":"Science"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1002\/smll.201601112","volume":"12","author":"Tan Y.","year":"2016","unstructured":"Tan Y.; Adhikari R.; Malvankar N.; Synthetic biological protein nanowires with high conductivity. Small Nanowires 2016,12(33),4481-4485","journal-title":"Small Nanowires"},{"key":"ref=44","year":"2014","unstructured":"Making Glowing Plants DNA. Genetics Available from: 2014"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.18388\/abp.2001_3863","volume":"48","author":"Zielenkiewicz U.","year":"2001","unstructured":"Zielenkiewicz U.; Ceg\u0142owski P.; Mechanisms of plasmid stable maintenance with special focus on plasmid addiction systems. Acta Biochim Pol 2001,48(4),1003-1023","journal-title":"Acta Biochim Pol"},{"key":"ref=46","first-page":"291","author":"Lius C.","year":"2002","unstructured":"Lius C.; Minton N.P.; Giaccia A.J.; Brown J.M.; Anti-cancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia\/necrosis. Gene Ther 2002(9),291-296","journal-title":"Gene Ther"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1128\/AAC.41.7.1521","volume":"41","author":"Boyd M.R.","year":"1997","unstructured":"Boyd M.R.; Gustafson K.R.; McMahon J.B.; Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrob Agents Chemother 1997,41(7),1521-1530","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"595575","DOI":"10.3389\/fcimb.2021.595575","volume":"11","author":"Wang L.","year":"2021","unstructured":"Wang L.; Chen T.; Wang H.; Engineered bacteria of MG1363-pMG36e-GLP-1 attenuated obesity-induced by high fat diet in mice. Front Cell Infect Microbiol 2021,11,595575","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12934-020-01350-z","volume":"19","author":"Bai L.","year":"2020","unstructured":"Bai L.; Gao M.; Cheng X.; Kang G.; Cao X.; Huang H.; Engineered butyrate-producing bacteria prevents high fat diet-induced obesity in mice. Microb Cell Fact 2020,19(1),94","journal-title":"Microb Cell Fact"},{"key":"ref=50","first-page":"1594","volume":"12","author":"Cunningham C.","year":"2001","unstructured":"Cunningham C.; Nemunaitis J.; A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Hum Gene Ther 2001,12(12),1594-1596","journal-title":"Hum Gene Ther"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/oby.22700","volume":"28","author":"Ma J.","year":"2020","unstructured":"Ma J.; Li C.; Wang J.; Gu J.; Genetically Engineered Escherichia coli Nissle 1917 Secreting GLP-1 Analog Exhibits Potential Antiobesity Effect in High-Fat Diet-Induced Obesity Mice. Obesity (Silver Spring) 2020,28(2),315-322","journal-title":"Obesity (Silver Spring)"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"8791","DOI":"10.1038\/ncomms9791","volume":"6","author":"Delalat B.","year":"2015","unstructured":"Delalat B.; Sheppard V.C.; Rasi Ghaemi S.; Targeted drug delivery using genetically engineered diatom biosilica. Nat Commun 2015,6,8791","journal-title":"Nat Commun"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.4155\/fmc.09.90","volume":"1","author":"McInnes S.J.","year":"2009","unstructured":"McInnes S.J.; Voelcker N.H.; Silicon-polymer hybrid materials for drug delivery. Future Med Chem 2009,1(6),1051-1074","journal-title":"Future Med Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/anie.200603928","volume":"46","author":"Poulsen N.","year":"2007","unstructured":"Poulsen N.; Berne C.; Spain J.; Kr\u00f6ger N.; Silica immobilization of an enzyme through genetic engineering of the diatom Thalassiosira pseudonana. Angew Chem Int Ed 2007,46(11),1843-1846","journal-title":"Angew Chem Int Ed"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1128\/AEM.06698-11","volume":"78","author":"Sheppard V.C.","year":"2012","unstructured":"Sheppard V.C.; Scheffel A.; Poulsen N.; Kr\u00f6ger N.; Live diatom silica immobilization of multimeric and redox-active enzymes. Appl Environ Microbiol 2012,78(1),211-218","journal-title":"Appl Environ Microbiol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1006\/immu.1993.1002","volume":"2","author":"Gronenborn A.M.","year":"1993","unstructured":"Gronenborn A.M.; Clore G.M.; Structural studies of immunoglobulin binding domains of streptococcal protein G. ImmunoMethods 1993,2,3-8","journal-title":"ImmunoMethods"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1208\/pt050340","volume":"5","author":"Saetern A.M.","year":"2004","unstructured":"Saetern A.M.; Flaten G.E.; Brandl M.; A method to determine the incorporation capacity of camptothecin in liposomes. AAPS PharmSciTech 2004,5(3),e40","journal-title":"AAPS PharmSciTech"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"eaba5996","DOI":"10.1126\/sciadv.aba5996","volume":"6; 6","author":"Qiao Y","year":"2020","unstructured":"Qiao Y; Yang F; Xie T; Engineered algae: A novel oxygengenerating\nsystem for effective treatment of hypoxic cancer. Sci\nAdv 2020,6; 6(21),eaba5996","journal-title":"Sci\nAdv"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1126\/science.1108639","volume":"308","author":"Scholte E.J.","year":"2005","unstructured":"Scholte E.J.; Ng\u2019habi K.; Kihonda J.; An entomopathogenic fungus for control of adult African malaria mosquitoes. Science 2005,308(5728),1641-1642","journal-title":"Science"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nrmicro1638","volume":"5","author":"Thomas M.B.","year":"2007","unstructured":"Thomas M.B.; Read A.F.; Can fungal biopesticides control malaria? Nat Rev Microbiol 2007,5(5),377-383","journal-title":"Nat Rev Microbiol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"e1000265","DOI":"10.1371\/journal.ppat.1000265","volume":"5","author":"Ghosh A.K.","year":"2009","unstructured":"Ghosh A.K.; Devenport M.; Jethwaney D.; Malaria parasite invasion of the mosquito salivary gland requires interaction between the Plasmodium TRAP and the Anopheles saglin proteins. PLoS Pathog 2009,5(1),e1000265","journal-title":"PLoS Pathog"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3389\/fbioe.2020.00293","volume":"8","author":"Wang Q.","year":"2020","unstructured":"Wang Q.; Zhong C.; Xiao H.; Genetic engineering of filamentous fungi for efficient protein expression and secretion. Front Bioeng Biotechnol 2020,8,293","journal-title":"Front Bioeng Biotechnol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1126\/science.289.5483.1352","volume":"289","author":"Steidler L.","year":"2000","unstructured":"Steidler L.; Hans W.; Schotte L.; Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000,289(5483),1352-1355","journal-title":"Science"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nbt.2465","volume":"31","author":"Kapoor N.","year":"2013","unstructured":"Kapoor N.; Liang W.; Marb\u00e1n E.; Cho H.C.; Direct conversion of quiescent cardiomyocytes to pacemaker cells by expression of Tbx18. Nat Biotechnol 2013,31(1),54-62","journal-title":"Nat Biotechnol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1161\/CIRCRESAHA.108.187062","volume":"104","author":"Wiese C.","year":"2009","unstructured":"Wiese C.; Grieskamp T.; Airik R.; Formation of the sinus node head and differentiation of sinus node myocardium are independently regulated by Tbx18 and Tbx3. Circ Res 2009,104(3),388-397","journal-title":"Circ Res"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.critrevonc.2015.04.001","volume":"95","author":"Jefferson A.","year":"2015","unstructured":"Jefferson A.; Cadet V.E.; Hielscher A.; The mechanisms of genetically modified vaccinia viruses for the treatment of cancer. Crit Rev Oncol Hematol 2015,95(3),407-416","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/biomedicines6040094","volume":"6","author":"Chulpanova D.S.","unstructured":"Chulpanova D.S.; Solovyeva V.V.; Kitaeva K.V.; Dunham S.P.; Khaiboullina S.F.; Rizvanov A.A.; 2018; Recombinant viruses for cancer therapy. Biomedicines ,6(4),94","journal-title":"Biomedicines"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/0042-6822(88)90635-6","volume":"164","author":"Buller R.M.","year":"1988","unstructured":"Buller R.M.; Chakrabarti S.; Moss B.; Fredrickson T.; Cell proliferative response to vaccinia virus is mediated by VGF. Virology 1988,164(1),182-192","journal-title":"Virology"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.coviro.2011.11.007","volume":"2","author":"Schmidt F.I.","year":"2012","unstructured":"Schmidt F.I.; Bleck C.K.; Mercer J.; Poxvirus host cell entry. Curr Opin Virol 2012,2(1),20-27","journal-title":"Curr Opin Virol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1128\/JVI.00692-09","volume":"84","author":"Guse K.","year":"2010","unstructured":"Guse K.; Sloniecka M.; Diaconu I.; Antiangiogenic arming of an oncolytic vaccinia virus enhances antitumor efficacy in renal cell cancer models. J Virol 2010,84(2),856-866","journal-title":"J Virol"},{"key":"ref=71","author":"Bhattacharya S.","year":"2004; 2004","unstructured":"Bhattacharya S.;  Genetically-modified virus explodes cancer cells 2004; 2004","journal-title":"Genetically-modified virus explodes cancer cells"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.2217\/imt.15.90","volume":"7","author":"Al Yaghchi C.","year":"2015","unstructured":"Al Yaghchi C.; Zhang Z.; Alusi G.; Lemoine N.R.; Wang Y.; Vaccinia virus, a promising new therapeutic agent for pancreatic cancer. Immunotherapy 2015,7(12),1249-1258","journal-title":"Immunotherapy"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/cas.13228","volume":"108","author":"Yamamoto Y.","year":"2017","unstructured":"Yamamoto Y.; Nagasato M.; Yoshida T.; Aoki K.; Recent advances in genetic modification of adenovirus vectors for cancer treatment. Cancer Sci 2017,108(5),831-837","journal-title":"Cancer Sci"},{"key":"ref=74","author":"Ossola A.","unstructured":"Ossola A.; 2015. FDA approves use of engineered herpes virus\nto treat cancer popular science Available from:"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/gt.2011.54","volume":"18","author":"Leja J.","year":"2011","unstructured":"Leja J.; Yu D.; Nilsson B.; Oncolytic adenovirus modified with somatostatin motifs for selective infection of neuroendocrine tumor cells. Gene Ther 2011,18(11),1052-1062","journal-title":"Gene Ther"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1097\/CJI.0b013e3181ace876","volume":"32","author":"Amato R.J.","year":"2009","unstructured":"Amato R.J.; Shingler W.; Goonewardena M.; Vaccination of renal cell cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) alone or administered in combination with interferon-alpha (IFN-alpha): a phase 2 trial. J Immunother 2009,32(7),765-772","journal-title":"J Immunother"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/jgm.397","volume":"5","author":"Rochlitz C.","year":"2003","unstructured":"Rochlitz C.; Figlin R.; Squiban P.; Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer. J Gene Med 2003,5(8),690-699","journal-title":"J Gene Med"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1158\/0008-5472.CAN-12-2448","volume":"73","author":"Hui E.P.","year":"2013","unstructured":"Hui E.P.; Taylor G.S.; Jia H.; Phase I trial of recombinant modified vaccinia ankara encoding Epstein-Barr viral tumor antigens in nasopharyngeal carcinoma patients. Cancer Res 2013,73(6),1676-1688","journal-title":"Cancer Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00262-010-0935-9","volume":"60","author":"Oudard S.","year":"2011","unstructured":"Oudard S.; Rixe O.; Beuselinck B.; A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings. Cancer Immunol Immunother 2011,60(2),261-271","journal-title":"Cancer Immunol Immunother"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s00262-016-1893-7","volume":"65","author":"Duggan M.C.","year":"2016","unstructured":"Duggan M.C.; Jochems C.; Donahue R.N.; A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-\u03b1-2b in patients with CEA-expressing carcinomas. Cancer Immunol Immunother 2016,65(11),1353-1364","journal-title":"Cancer Immunol Immunother"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.chom.2020.04.003","volume":"27","author":"Yeh M.T.","year":"2020","unstructured":"Yeh M.T.; Bujaki E.; Dolan P.T.; Engineering the live-attenuated polio vaccine to prevent reversion to virulence. Cell Host Microbe 2020,27(5),736-751.e8","journal-title":"Cell Host Microbe"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1186\/s12889-020-09039-z","volume":"20","author":"Bell G.J.","year":"2020","unstructured":"Bell G.J.; Loop M.S.; Mvalo T.; Environmental modifiers of RTS,S\/AS01 malaria vaccine efficacy in Lilongwe, Malawi. BMC Public Health 2020,20(1),910","journal-title":"BMC Public Health"},{"key":"ref=83","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002461","author":"Ota MO","unstructured":"Ota MO; Odutola AA; Owiafe PK; 2011; Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants. Sci Transl Med 3; 88: 88ra56.","journal-title":"Sci Transl Med"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.ymthe.2006.01.013","volume":"13","author":"Nemunaitis J.","year":"2006","unstructured":"Nemunaitis J.; Meyers T.; Senzer N.; Phase I Trial of sequential administration of recombinant DNA and adenovirus expressing L523S protein in early stage non-small-cell lung cancer. Mol Ther 2006,13(6),1185-1191","journal-title":"Mol Ther"},{"key":"ref=85","unstructured":"Genetically modified organisms: Applications and decisions information\nabout the release of genetically modified organisms\n(GMOs) for research purposes application and consent process.\nDept. of Environment, Food"},{"key":"ref=86","year":"2014","unstructured":"Restrictions on genetically modified organisms Law Library of Congress (U.S.)2014","journal-title":"Restrictions on genetically modified organisms"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nnano.2011.119","volume":"6","author":"Malvankar N.S.","year":"2011","unstructured":"Malvankar N.S.; Vargas M.; Nevin K.P.; Tunable metallic-like conductivity in microbial nanowire networks. Nat Nanotechnol 2011,6(9),573-579","journal-title":"Nat Nanotechnol"},{"key":"ref=88","first-page":"00105","volume":"4","author":"Malvanka N.","year":"2013","unstructured":"Malvanka N.; Vargas M.; Nevin K.; Aromatic amino acids required for pili conductivity and long-range extracellular electron transport in Geobacter sulfurreducens. Bio 2013,4(2),00105-00113","journal-title":"Bio"},{"key":"ref=89","year":"2013","unstructured":"Guidance 21: Medicines produced by genetic manipulation, Available from: 2013"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612828666220128102823","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/200629\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612828666220128102823","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T17:09:09Z","timestamp":1691687349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/200629\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":89,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612828666220128102823","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-04-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}